BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33996610)

  • 1. Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Qian X; Fu M; Zheng J; Zhou J; Zhou J
    Front Oncol; 2021; 11():680191. PubMed ID: 33996610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.
    Liu Y; Wang W; Wu F; Gao G; Xu J; Li X; Zhao C; Yang S; Mao S; Pan Y; Jia K; Shao C; Chen B; Ren S; Zhou C
    Transl Lung Cancer Res; 2021 Mar; 10(3):1512-1524. PubMed ID: 33889526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
    Icht O; Leader A; Batat E; Yosef L; Shochat T; Goldstein DA; Dudnik E; Spectre G; Raanani P; Hammerman A; Zer A
    Oncologist; 2023 Jun; 28(6):e391-e396. PubMed ID: 37014824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis.
    Zhu VW; Zhao JJ; Gao Y; Syn NL; Zhang SS; Ou SI; Bauer KA; Nagasaka M
    Lung Cancer; 2021 Jul; 157():147-155. PubMed ID: 34049720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations.
    Wang HY; Wu SG; Lin YT; Chen CY; Shih JY
    ESMO Open; 2022 Dec; 7(6):100742. PubMed ID: 36493600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
    Abufarhaneh M; Pandya RK; Alkhaja A; Iansavichene A; Welch S; Lazo-Langner A
    Thromb Res; 2022 May; 213():47-56. PubMed ID: 35290837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events.
    Ng TL; Smith DE; Mushtaq R; Patil T; Dimou A; Yang S; Liu Q; Li X; Zhou C; Jones RT; Tu MM; Yan F; Bowman IA; Liu SV; Newkirk S; Bauml J; Doebele RC; Aisner DL; Gao D; Ren S; Camidge DR
    J Thorac Oncol; 2019 Apr; 14(4):596-605. PubMed ID: 30543838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Noumegni SR; Hoffmann C; Tromeur C; Lacut K; Didier R; Couturaud F; Bressollette L
    Thromb Res; 2021 Jul; 203():172-185. PubMed ID: 34029849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.
    Dou F; Zhang Y; Yi J; Zhu M; Zhang S; Zhang D; Zhang Y
    Thromb Res; 2020 Feb; 186():36-41. PubMed ID: 31864154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis.
    Li M; Guo Q; Hu W
    Thromb Res; 2019 Jan; 173():48-56. PubMed ID: 30471508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
    Chiari R; Ricciuti B; Landi L; Morelli AM; Delmonte A; Spitaleri G; Cortinovis DL; Lamberti G; Facchinetti F; Pilotto S; Verusio C; Chella A; Bonanno L; Galetta D; Cappuzzo F
    Clin Lung Cancer; 2020 Jan; 21(1):15-20. PubMed ID: 31607443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.
    Lee YG; Kim I; Lee E; Bang SM; Kang CH; Kim YT; Kim HJ; Wu HG; Kim YW; Kim TM; Lee KW; Lee SH; Kim DW; Heo DS
    Thromb Haemost; 2014 Jun; 111(6):1112-20. PubMed ID: 24477503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer.
    Su Y; Huo M; Hua L; Zhang Y; Yi J; Zhang S; Li J; Zhang Y
    Cancer Manag Res; 2021; 13():4031-4040. PubMed ID: 34040443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.
    Dou F; Li H; Zhu M; Liang L; Zhang Y; Yi J; Zhang Y
    Respir Res; 2018 May; 19(1):88. PubMed ID: 29743116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC.
    Al-Samkari H; Leiva O; Dagogo-Jack I; Shaw A; Lennerz J; Iafrate AJ; Bendapudi PK; Connors JM
    J Thorac Oncol; 2020 Sep; 15(9):1497-1506. PubMed ID: 32437899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism.
    Wang J; Hu B; Li T; Miao J; Zhang W; Chen S; Sun Y; Cui S; Li H
    Ann Transl Med; 2019 Dec; 7(23):724. PubMed ID: 32042740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
    Zer A; Moskovitz M; Hwang DM; Hershko-Klement A; Fridel L; Korpanty GJ; Dudnik E; Peled N; Shochat T; Leighl NB; Liu G; Feld R; Burkes R; Wollner M; Tsao MS; Shepherd FA
    Clin Lung Cancer; 2017 Mar; 18(2):156-161. PubMed ID: 27913214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: A systematic review and meta-analysis.
    Puri A; Dai H; Giri M; Wu C; Huang H; Zhao Q
    Front Cardiovasc Med; 2022; 9():917572. PubMed ID: 35958406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.